Myomo, Inc. Submits Form 144 Filing – Find Out More About the SEC Alert
MYOMO, INC. (0001369290) has filed a Form 144 with the Securities and Exchange Commission (SEC). The filing is significant as it indicates that certain individuals, such as company insiders or affiliates, are planning to sell shares of MYOMO, INC. Common Stock. Form 144 is required by the SEC to be filed when insiders of a company plan to sell their shares, providing transparency and allowing investors to track insider trading activities.
MYOMO, INC. is a medical technology company that designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders. The company’s innovative products help restore mobility and improve the quality of life for individuals with neurological conditions. For more information about MYOMO, INC., you can visit their website at https://www.myomo.com.
Form 144 is a notice of proposed sale of securities filed with the SEC by an affiliate of the issuing company. It is used to register the proposed sale of restricted securities or securities held by an affiliate. The form must be filed with the SEC when the amount of securities to be sold during any three-month period exceeds 5,000 shares or units or has an aggregate sales price in excess of $50,000.
Read More:
Myomo, Inc. SEC Filing Reveals Important Information – 144 Filing Details Uncovered
